X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (7807) 7807
Publication (425) 425
Newsletter (52) 52
Book Review (46) 46
Book Chapter (15) 15
Magazine Article (12) 12
Newspaper Article (8) 8
Conference Proceeding (4) 4
Dissertation (4) 4
Book / eBook (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
animals (4226) 4226
male (4210) 4210
desipramine - pharmacology (3555) 3555
desipramine (3108) 3108
rats (3002) 3002
humans (2847) 2847
female (2033) 2033
pharmacology & pharmacy (1785) 1785
neurosciences (1279) 1279
psychiatry (1279) 1279
adult (1274) 1274
norepinephrine - metabolism (1061) 1061
desipramine - therapeutic use (957) 957
middle aged (880) 880
antidepressants (795) 795
dose-response relationship, drug (790) 790
antidepressive agents - pharmacology (764) 764
rats, inbred strains (745) 745
imipramine (712) 712
time factors (703) 703
depression (698) 698
mice (691) 691
in vitro techniques (651) 651
index medicus (617) 617
depressive disorder - drug therapy (613) 613
fluoxetine (547) 547
brain - metabolism (541) 541
rats, sprague-dawley (541) 541
imipramine - pharmacology (500) 500
drug interactions (461) 461
kinetics (461) 461
antidepressive agents, tricyclic - pharmacology (448) 448
aged (437) 437
adolescent (436) 436
desipramine - administration & dosage (436) 436
desipramine - blood (430) 430
norepinephrine (426) 426
clinical neurology (422) 422
brain (414) 414
serotonin - metabolism (407) 407
serotonin (401) 401
brain - drug effects (388) 388
rats, wistar (387) 387
double-blind method (383) 383
noradrenaline (381) 381
motor activity - drug effects (371) 371
norepinephrine - pharmacology (352) 352
desipramine - metabolism (351) 351
fluoxetine - pharmacology (348) 348
behavior, animal - drug effects (347) 347
tricyclic antidepressants (342) 342
rat (326) 326
dopamine (325) 325
cocaine - pharmacology (324) 324
depression - drug therapy (324) 324
amitriptyline (323) 323
adrenergic uptake inhibitors - pharmacology (322) 322
electric stimulation (321) 321
reserpine - pharmacology (318) 318
dopamine - metabolism (315) 315
treatment outcome (313) 313
tritium (312) 312
desipramine - adverse effects (301) 301
antidepressant (298) 298
antidepressive agents - therapeutic use (292) 292
biochemistry & molecular biology (286) 286
antidepressive agents, tricyclic - therapeutic use (285) 285
drugs (269) 269
drug synergism (263) 263
double-blind (260) 260
depressive disorder - psychology (259) 259
research (259) 259
cocaine (258) 258
major depression (255) 255
child (254) 254
blood pressure - drug effects (253) 253
psychiatric status rating scales (253) 253
amitriptyline - pharmacology (252) 252
imipramine - therapeutic use (248) 248
disease models, animal (242) 242
neurons - drug effects (241) 241
cerebral cortex - metabolism (232) 232
imipramine - blood (231) 231
neurons - metabolism (225) 225
imipramine - metabolism (223) 223
serotonin uptake inhibitors - pharmacology (223) 223
rabbits (222) 222
rat-brain (222) 222
norepinephrine - physiology (221) 221
brain chemistry - drug effects (217) 217
myocardium - metabolism (217) 217
drug therapy, combination (213) 213
heart rate - drug effects (212) 212
j ve psychiatry (209) 209
receptors (206) 206
cerebral cortex - drug effects (201) 201
forced swimming test (194) 194
clinical trials as topic (192) 192
swimming (192) 192
drug therapy (188) 188
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (7559) 7559
German (129) 129
French (65) 65
Japanese (36) 36
Russian (32) 32
Spanish (22) 22
Italian (19) 19
Polish (6) 6
Portuguese (6) 6
Czech (5) 5
Swedish (5) 5
Chinese (3) 3
Danish (3) 3
Norwegian (3) 3
Dutch (2) 2
Afrikaans (1) 1
Hungarian (1) 1
Korean (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Cytokine, ISSN 1043-4666, 04/2016, Volume 80, p. 26
* Desipramine was given orally for 21days. * Desipramine inhibited the LPS-induced IL-1[beta] levels in the brain and plasma of rats. * The most important drug... 
Desipramine | Mitogens
Journal Article
Journal of Colloid And Interface Science, ISSN 0021-9797, 02/2016, Volume 463, pp. 279 - 287
Journal Article
Autonomic Neuroscience: Basic and Clinical, ISSN 1566-0702, 07/2017, Volume 205, p. 21
Desipramine (DMI) is a blocker of neuronal norepinephrine (NE) uptake transporter. Although intravenous DMI has been shown to cause centrally-mediated... 
Desipramine | Acetylcholine | Physiological aspects
Journal Article
Journal of Pain and Symptom Management, ISSN 0885-3924, 07/2019, Volume 58, p. 171
Journal Article
American Journal of Psychiatry, ISSN 0002-953X, 12/2014, Volume 171, Issue 12, pp. 1297 - 1309
Objective:The authors compared the effectiveness of fluoxetine and desipramine treatment in a prospective double-blind pharmacogenetics study in... 
COST-EFFECTIVENESS | PRIMARY-CARE | METAANALYSIS | EFFICACY | PSYCHIATRY | TOLERABILITY | TREATMENT RESPONSE | HISPANICS | MAJOR DEPRESSIVE DISORDER | SCALE | ADHERENCE | Brain-Derived Neurotrophic Factor - genetics | Predictive Value of Tests | Prospective Studies | Epigenesis, Genetic | Humans | Middle Aged | Male | Antidepressive Agents, Second-Generation - therapeutic use | Desipramine - adverse effects | Psychiatric Status Rating Scales | Desipramine - therapeutic use | Adult | Female | Fluoxetine - therapeutic use | Fluoxetine - adverse effects | Depressive Disorder, Major - drug therapy | Genome-Wide Association Study | Mexican Americans | Pharmacogenetics | Adrenergic Uptake Inhibitors - therapeutic use | Double-Blind Method | Drug Administration Schedule | Serotonin Uptake Inhibitors - therapeutic use | Genotype | Treatment Outcome | Desipramine - administration & dosage | Antidepressive Agents - therapeutic use | Depressive Disorder, Major - psychology | Antidepressive Agents, Tricyclic - therapeutic use | Fluoxetine - administration & dosage | Antidepressive Agents - administration & dosage | Aged | Polymorphism, Single Nucleotide | Antidepressive Agents - adverse effects | Depressive Disorder, Major - diagnosis | Research Design | Brain | Epigenetic inheritance | Fluoxetine | Patient outcomes | Depression, Mental | Research | Pharmaceutical research | Genetic research | Genetic aspects | Dosage and administration | Methylation | Drug therapy | Health aspects | drug response | pharmacogenomics | fluoxetine | methylation sites | epigenetic | Mexican-American population | antidepressants | depression | desipramine
Journal Article
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, ISSN 0928-0987, 05/2019, Volume 133, pp. 264 - 274
Journal Article
Journal Article
International Clinical Psychopharmacology, ISSN 0268-1315, 03/2013, Volume 28, Issue 2, pp. 99 - 105
The results of two single-center, two-period, open-label trials that evaluated the effects of multiple doses of desvenlafaxine on the pharmacokinetics of... 
SYSTEM | desvenlafaxine | EFFICACY | DRUG-INTERACTIONS | SAFETY | PSYCHIATRY | desipramine | REUPTAKE-INHIBITOR | CYTOCHROME-P450 2D6 | 100 MG/DAY | IN-VITRO | ANTIDEPRESSANTS | pharmacokinetics | PHARMACOLOGY & PHARMACY | MAJOR DEPRESSIVE DISORDER | Cytochrome P-450 CYP2D6 Inhibitors | Cyclohexanols - adverse effects | Neurotransmitter Uptake Inhibitors - adverse effects | Antidepressive Agents, Tricyclic - pharmacokinetics | Humans | Middle Aged | Half-Life | Biological Availability | Male | Metabolic Clearance Rate | Dose-Response Relationship, Drug | Enzyme Inhibitors - administration & dosage | Young Adult | Desipramine - adverse effects | Desipramine - urine | Drug Interactions | Neurotransmitter Uptake Inhibitors - administration & dosage | Desvenlafaxine Succinate | Adult | Female | Desipramine - analogs & derivatives | Enzyme Inhibitors - adverse effects | Cytochrome P-450 CYP2D6 - genetics | Desipramine - blood | Antidepressive Agents, Tricyclic - urine | Polymorphism, Genetic | Desipramine - pharmacokinetics | Antidepressive Agents, Tricyclic - blood | Metabolic Detoxication, Phase I | Adolescent | Antidepressive Agents, Tricyclic - adverse effects | Cytochrome P-450 CYP2D6 - metabolism | Antidepressive Agents - administration & dosage | Antidepressive Agents - adverse effects | Cyclohexanols - administration & dosage | Clinical trials | Enzymes | Pharmacokinetics | Desipramine | Cytochrome P450 | CYP2D6 protein
Journal Article
Science, ISSN 0036-8075, 9/2007, Volume 317, Issue 5843, pp. 1390 - 1393
Tricyclic antidepressants exert their pharmacological effect--inhibiting the reuptake of serotonin, norepinephrine, and dopamine--by directly blocking... 
Molecules | Salts | Neurotransmitters | Antidepressants | Reuptake | Serotonin plasma membrane transport proteins | Neurotransmitter transport proteins | Reports | Pharmacology | Inhibitory concentration 50 | Crystal structure | SENSITIVE DOPAMINE TRANSPORTER | NOREPINEPHRINE TRANSPORTERS | MULTIDISCIPLINARY SCIENCES | ION-BINDING | MONOAMINE TRANSPORTERS | SEROTONIN | INHIBITORS | Dopamine - chemistry | Antidepressive Agents, Tricyclic - metabolism | Caenorhabditis elegans Proteins - chemistry | Humans | Bacterial Proteins - chemistry | Caenorhabditis elegans Proteins - metabolism | Molecular Sequence Data | Crystallography, X-Ray | Serotonin - chemistry | Dopamine Uptake Inhibitors - metabolism | Drosophila Proteins - metabolism | Antidepressive Agents, Tricyclic - chemistry | Neurotransmitter Uptake Inhibitors - metabolism | Desipramine - metabolism | Conserved Sequence | Binding Sites | Dopamine - metabolism | Serotonin Uptake Inhibitors - metabolism | Amino Acid Sequence | Cell Line | Leucine - metabolism | Norepinephrine Plasma Membrane Transport Proteins - antagonists & inhibitors | Models, Molecular | Serotonin Uptake Inhibitors - chemistry | Drosophila Proteins - chemistry | Plasma Membrane Neurotransmitter Transport Proteins - metabolism | Leucine - chemistry | Sequence Homology, Amino Acid | Animals | Norepinephrine - metabolism | Desipramine - chemistry | Neurotransmitter Uptake Inhibitors - chemistry | Norepinephrine - chemistry | Serotonin - metabolism | Dopamine Uptake Inhibitors - chemistry | Protein Binding | Bacterial Proteins - metabolism | Plasma Membrane Neurotransmitter Transport Proteins - chemistry | Protein Conformation | Norepinephrine Plasma Membrane Transport Proteins - metabolism | Norepinephrine Plasma Membrane Transport Proteins - chemistry | Leucine | Structure | Desipramine | Health aspects | Antidepressants, Tricyclic | Inhibitor drugs | Psychiatry | Binding sites
Journal Article
Lancet, The, ISSN 0140-6736, 2016, Volume 388, Issue 10047, pp. 881 - 890
Summary Background Major depressive disorder is one of the most common mental disorders in children and adolescents. However, whether to use pharmacological... 
Internal Medicine | TRIALS | MEDICINE, GENERAL & INTERNAL | ACCEPTABILITY | MENTAL-HEALTH-CARE | TRENDS | GUIDELINES | Mianserin - adverse effects | Triazoles - administration & dosage | Triazoles - adverse effects | Humans | Citalopram - adverse effects | Sertraline - adverse effects | Venlafaxine Hydrochloride - adverse effects | Imipramine - administration & dosage | Paroxetine - adverse effects | Mianserin - analogs & derivatives | Paroxetine - administration & dosage | Desipramine - adverse effects | Nortriptyline - administration & dosage | Nortriptyline - adverse effects | Mianserin - administration & dosage | Child | Fluoxetine - adverse effects | Depressive Disorder, Major - drug therapy | Clomipramine - administration & dosage | Duloxetine Hydrochloride - adverse effects | Double-Blind Method | Drug Administration Schedule | Treatment Outcome | Clomipramine - adverse effects | Evidence-Based Medicine | Desipramine - administration & dosage | Randomized Controlled Trials as Topic | Venlafaxine Hydrochloride - administration & dosage | Citalopram - administration & dosage | Confounding Factors (Epidemiology) | Sertraline - administration & dosage | Adolescent | Amitriptyline - adverse effects | Bayes Theorem | Fluoxetine - administration & dosage | Duloxetine Hydrochloride - administration & dosage | Antidepressive Agents - administration & dosage | Antidepressive Agents - adverse effects | Research Design | Amitriptyline - administration & dosage | Imipramine - adverse effects | Psychological aspects | Medical colleges | Neurosciences | Drugs and youth | Rankings | Comparative analysis | Child psychopathology | Major depressive disorder | Antidepressants, Tricyclic | Pediatric pharmacology | Mental illness | Studies | Teenagers | Mental depression | Antidepressants | Meta-analysis | Children & youth
Journal Article
Cardiovascular Toxicology, ISSN 1530-7905, 06/2018, Volume 18, Issue 3, p. 252
To access, purchase, authenticate, or subscribe to the full-text of this article, please visit this link: http://dx.doi.org/10.1007/s12012-017-9435-x We... 
Medical colleges | Desipramine | Smooth muscle
Journal Article